Terms: = Liver cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Prognosis
257 results:
1. Indoxyl sulfate contributes to colorectal cancer cell proliferation and increased egfr expression by activating AhR and Akt.
Ichisaka Y; Yano S; Nishimura K; Niwa T; Shimizu H
Biomed Res; 2024; 45(2):57-66. PubMed ID: 38556263
[TBL] [Abstract] [Full Text] [Related]
2. Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease.
Yang X; Lin Y; Huang J; Chi Y; Wu Y; Lin S
Sci Rep; 2024 Mar; 14(1):5923. PubMed ID: 38467667
[TBL] [Abstract] [Full Text] [Related]
3. SERPINE2 promotes liver cancer metastasis by inhibiting c-Cbl-mediated egfr ubiquitination and degradation.
Zhang S; Jia X; Dai H; Zhu X; Song W; Bian S; Wu H; Chen S; Tang Y; Chen J; Jin C; Zhou M; Xie H; Zheng S; Song P
Cancer Commun (Lond); 2024 Mar; 44(3):384-407. PubMed ID: 38407942
[TBL] [Abstract] [Full Text] [Related]
4. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
5. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing egfr mRNA and pSTAT3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract] [Full Text] [Related]
6. Deep Learning Prediction Boosts Phosphoproteomics-Based Discoveries Through Improved Phosphopeptide Identification.
Yi X; Wen B; Ji S; Saltzman AB; Jaehnig EJ; Lei JT; Gao Q; Zhang B
Mol Cell Proteomics; 2024 Feb; 23(2):100707. PubMed ID: 38154692
[TBL] [Abstract] [Full Text] [Related]
7. A highly oxidized germacranolide from elephantopus tomentosus inhibits the growth of hepatocellular carcinoma cells by targeting egfr in vitro and in vivo.
Li Q; Niu JQ; Jia JH; Xu W; Bai M; Yao GD; Song SJ
Bioorg Chem; 2024 Feb; 143():107007. PubMed ID: 38039928
[TBL] [Abstract] [Full Text] [Related]
8. Analysis of an Unselected Patient Cohort With Advanced Colorectal Carcinoma from a Maximum Care Center.
Zhang XW; Mohr J; Halama N; Koschny R
Anticancer Res; 2023 Dec; 43(12):5589-5596. PubMed ID: 38030166
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic and predictive biomarkers for anti-egfr monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.
Lu X; Li Y; Li Y; Zhang X; Shi J; Feng H; Yu Z; Gao Y
BMC Cancer; 2023 Nov; 23(1):1117. PubMed ID: 37974093
[TBL] [Abstract] [Full Text] [Related]
10. A retrospective real-world study: the efficacy of immune-related combination therapies in advanced non-small cell lung cancer after resistance to egfr-TKIs.
Cai R; Liu Y; Yu M; Sha H; Guo M; Chen Y; Ye J; Zhou G; Fang Y; Shen B
Cancer Immunol Immunother; 2023 Dec; 72(12):4355-4365. PubMed ID: 37907645
[TBL] [Abstract] [Full Text] [Related]
11. A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network.
Zhang HY; Zhu JJ; Liu ZM; Zhang YX; Chen JJ; Chen KD
Hepatobiliary Pancreat Dis Int; 2024 Jun; 23(3):272-287. PubMed ID: 37407412
[TBL] [Abstract] [Full Text] [Related]
12. Impact of Renal Function on the prognosis of Patients Receiving Atezolizumab/Bevacizumab Combination Therapy and Lenvatinib Monotherapy for Unresectable Hepatocellular Carcinoma.
Takada H; Yamashita K; Osawa L; Komiyama Y; Nakakuki N; Muraoka M; Suzuki Y; Sato M; Takano S; Fukasawa M; Yamaguchi T; Maekawa S; Takahashi K; Uchimura K; Enomoto N
Oncology; 2023; 101(10):609-623. PubMed ID: 37279708
[TBL] [Abstract] [Full Text] [Related]
13. [A Case of Multiple Brain Metastases after Surgery for Lung cancer Successfully Treated with Osimertinib].
Takeuchi K; Hayakawa N; Ouchi M
Gan To Kagaku Ryoho; 2023 May; 50(5):631-633. PubMed ID: 37218327
[TBL] [Abstract] [Full Text] [Related]
14. Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis.
Schlesinger S; Lang A; Christodoulou N; Linnerz P; Pafili K; Kuss O; Herder C; Neuenschwander M; Barbaresko J; Roden M
Diabetologia; 2023 Aug; 66(8):1395-1412. PubMed ID: 37204441
[TBL] [Abstract] [Full Text] [Related]
15. Ring finger protein 12 activates AKT signalling to promote the progression of liver cancer by interacting with egfr.
Yu C; Rao D; Wang T; Sheng J; Lv E; Zhang L; Lu X; Yu J; Liang H; Song J; Huang W
J Cell Mol Med; 2023 Jun; 27(11):1523-1538. PubMed ID: 37132043
[TBL] [Abstract] [Full Text] [Related]
16. Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments.
Ros J; Matito J; Villacampa G; Comas R; Garcia A; Martini G; Baraibar I; Saoudi N; Salvà F; Martin Á; Antista M; Toledo R; Martinelli E; Pietrantonio F; Boccaccino A; Cremolini C; Dientsmann R; Tabernero J; Vivancos A; Elez E
Ann Oncol; 2023 Jun; 34(6):543-552. PubMed ID: 36921693
[TBL] [Abstract] [Full Text] [Related]
17. The Prognostic Value and the Oncogenic and Immunological Roles of Vacuolar Protein Sorting Associated Protein 26 A in Pancreatic Adenocarcinoma.
Hou J; Wu H; Xu B; Shang J; Xu X; Li G; Zhang H; Zhang W; Deng Y; Hong X; Hu T; Zhang M; Zhan Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834898
[TBL] [Abstract] [Full Text] [Related]
18. Aberrant fucosylation sustains the NOTCH and egfr/NF-κB pathways and has a prognostic value in human intrahepatic cholangiocarcinoma.
Ament CE; Steinmann S; Evert K; Pes GM; Ribback S; Gigante I; Pizzuto E; Banales JM; Rodrigues PM; Olaizola P; Wang H; Giannelli G; Chen X; Evert M; Calvisi DF
Hepatology; 2023 Dec; 78(6):1742-1754. PubMed ID: 36789652
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic features of gastric glomus tumor: A report of 15 cases and literature review.
Deng M; Luo R; Huang J; Luo Y; Song Q; Liang H; Xu C; Yuan W; Hou Y
Pathol Oncol Res; 2022; 28():1610824. PubMed ID: 36699621
[No Abstract] [Full Text] [Related]
20. Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
Kozuka R; Tamori A; Enomoto M; Muto-Yukawa Y; Odagiri N; Kotani K; Motoyama H; Kawamura E; Hagihara A; Fujii H; Uchida-Kobayashi S; Kawada N
J Viral Hepat; 2023 May; 30(5):374-385. PubMed ID: 36583600
[TBL] [Abstract] [Full Text] [Related]
[Next]
